A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity.
Tao H, Cheng L, Liu L, Wang H, Jiang Z, Qiang X, Xing L, Xu Y, Cai X, Yao J, Wang M, Qiu Z.
Tao H, et al. Among authors: qiu z.
Cancer Lett. 2020 Nov 28;493:91-101. doi: 10.1016/j.canlet.2020.08.009. Epub 2020 Aug 15.
Cancer Lett. 2020.
PMID: 32805322